1. Home
  2. CRBU vs TCX Comparison

CRBU vs TCX Comparison

Compare CRBU & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • TCX
  • Stock Information
  • Founded
  • CRBU 2011
  • TCX 1992
  • Country
  • CRBU United States
  • TCX Canada
  • Employees
  • CRBU N/A
  • TCX N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • TCX EDP Services
  • Sector
  • CRBU Health Care
  • TCX Technology
  • Exchange
  • CRBU Nasdaq
  • TCX Nasdaq
  • Market Cap
  • CRBU 203.9M
  • TCX 203.7M
  • IPO Year
  • CRBU 2021
  • TCX 1996
  • Fundamental
  • Price
  • CRBU $2.08
  • TCX $19.95
  • Analyst Decision
  • CRBU Strong Buy
  • TCX
  • Analyst Count
  • CRBU 3
  • TCX 0
  • Target Price
  • CRBU $9.33
  • TCX N/A
  • AVG Volume (30 Days)
  • CRBU 4.6M
  • TCX 17.1K
  • Earning Date
  • CRBU 11-07-2025
  • TCX 11-06-2025
  • Dividend Yield
  • CRBU N/A
  • TCX N/A
  • EPS Growth
  • CRBU N/A
  • TCX N/A
  • EPS
  • CRBU N/A
  • TCX N/A
  • Revenue
  • CRBU $9,121,000.00
  • TCX $384,728,000.00
  • Revenue This Year
  • CRBU $8.06
  • TCX N/A
  • Revenue Next Year
  • CRBU N/A
  • TCX N/A
  • P/E Ratio
  • CRBU N/A
  • TCX N/A
  • Revenue Growth
  • CRBU N/A
  • TCX 8.03
  • 52 Week Low
  • CRBU $0.66
  • TCX $13.27
  • 52 Week High
  • CRBU $3.54
  • TCX $23.38
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 39.13
  • TCX 64.11
  • Support Level
  • CRBU $2.28
  • TCX $18.47
  • Resistance Level
  • CRBU $3.53
  • TCX $19.54
  • Average True Range (ATR)
  • CRBU 0.27
  • TCX 0.62
  • MACD
  • CRBU -0.07
  • TCX 0.12
  • Stochastic Oscillator
  • CRBU 7.81
  • TCX 47.95

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

Share on Social Networks: